Concepedia

Pharmacokinetic/pharmacodynamic modelling-based optimisation of administration schedule for the histone deacetylase inhibitor abexinostat (S78454/PCI-24781) in phase I

Sylvain Fouliard, Renata Robert, Anne Jacquet-Bescond, Quentin Chalret du Rieu, Sriram Balasubramanian, David Loury, Yohann Loriot, Antoine Hollebecque, Ioana Kloos, Jean‐Charles Soria,

European Journal of Cancer · 2013 · 33 citations · 13 references

DOI

Concepts

References

13

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

Radojka M. Savić, Mats O. Karlsson · The AAPS Journal · 2009 · 614 citations · Full text

, , +11

p21 <sup>WAF1</sup> is required for butyrate-mediated growth inhibition of human colon cancer cells

Sonia Y. Archer, Shufen Meng, Amy Shei et al. · Proceedings of the National Academy of Sciences · 1998 · 537 citations · Full text

, , +16

Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs

Lena E. Friberg, Anja Henningsson, Hugo Maas et al. · Journal of Clinical Oncology · 2002 · 528 citations

, , +17

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

Christophe Deroanne, Karine Bonjean, S. Servotte et al. · Oncogene · 2002 · 412 citations

, , +14

HDAC inhibitors: Clinical update and mechanism-based potential

Keith B. Glaser · Biochemical Pharmacology · 2007 · 349 citations

, , +7